New York, NY -- (SBWIRE) -- 12/04/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: dELiA*s, Inc (NASDAQ:DLIA), Arena Pharmaceuticals, Inc (NASDAQ:ARNA), Exxon Mobil Corporation (NYSE:XOM), Net Profits Ten Inc (OTCBB:FARE)
dELiA's, Inc (NASDAQ:DLIA) showed a volume of 1.08 million shares by the end of last trade whereas the average volume of the stock remained 1.37 million shares. The stock opened the session at $1.15 but then moved to $1.12. At that price, the stock showed a negative performance of -2.61%. dELiA's, Inc. is a retail company comprised of two lifestyle brands primarily targeting teenage girls and young women. The Company generates revenue by selling predominantly to teenage consumers through direct mail catalogs, Websites and retail stores. It operates in dELiA's brand. Through its e-commerce Webpages, catalogs and retail stores, dELiA's (the brand) offers a variety of product categories to teenage girls to cater to an entire lifestyle. Through its catalogs and the e-commerce Webpages,
Will DLIA Get Buyers Even After The Recent Rally? Find Out Here
Arena Pharmaceuticals, Inc (NASDAQ:ARNA) opened the session at $6.69 and closed the session at $6.60. The stock showed a negative performance of -0.90% in previous trading session. Traded with volume of 5.57 million shares in the prior session and the average volume of the stock remained 5.77 million shares. Arena Pharmaceuticals, Inc. (Arena) is a biopharmaceutical company focused on discovering, developing and commercializing drugs that target G protein-coupled receptors. Its wholly owned subsidiary, Arena Pharmaceuticals GmbH (Arena GmbH), has granted Eisai Inc., rights to commercialize BELVIQ in the United States.
Has ARNA Found The Bottom And Ready To Gain Momentum? Find Out Here
Exxon Mobil Corporation (NYSE:XOM) opened the session at $93.60 and closed the session at $94.39. The stock showed a positive performance of 0.93% in previous trading session. Traded with volume of 12.61 million shares in the prior session and the average volume of the stock remained 12.40 million shares. The beta of the stock remained 0.67. Exxon Mobil Corporation (Exxon Mobil) is a manufacturer and marketer of commodity petrochemicals, including olefins, aromatics, polyethylene and polypropylene plastics and a range of specialty products. The Company has a number of divisions and affiliates with names that include ExxonMobil, Exxon, Esso or Mobil. Divisions and affiliated companies of ExxonMobil operate or market products in the United States and other countries of the world.
Why Should Investors Buy XOM After The Recent Gain? Just Go Here and Find Out
Net Profits Ten Inc (OTCBB:FARE) the stock advanced 9.59% and finished the session at $0.120. Traded with volume of 3.40 million shares in the prior session and the average volume of the stock remained 161.54 million shares.
Will FARE Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)